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1. Introduction 
Recent studies have shown that the reaction of 
chloroacetaldehyde with adenine or cytosine deriva- 
fives leads to the formation of highly fluorescent com- 
pounds [1-4].  The present paper describes the con- 
densation of chloroacetaldehyde with flavin adenine 
dinucleotide (FAD) resulting in a biologically active 
1, N 6-ethenoadenosine a alog (abbreviated FAD, 
fig. 1). 
2. Materials and niethods 
Redistilled chloroacetaldehyde diethyl acetal 
(Aldrich Chemical Co., Milwaukee, Wisc.) was 
hydrolyzed by refluxing with 5% H~SO~ for 1 hr. 
The chloroacetaldehyde obtained by distillation (b.p. 
85-6°; semicarbazone, m.p. 148 ° [5]) was dissolved 
in water to yield an approx. 2 M solution. This stock 
solution (unadjusted pH approx. 4.0) when kept at 
2 ° was stable for at least 1 month. 
eFAD.HCI (flavin-1, N6-ethenoadenine dinucleo- 
tide hydrochloride): A solution of 83 mg (0.1 mmoles) 
of flavin-adenine dinu'cleotide (disodium salt, 96% 
purity) in 20 ml of 2 M aqueous chloroacetaldehyde 
was stirred at 37 ° for 24 hr and then evaporated to
dryness on a flash evaporator at a temperature < 40 °. 
Recrystallization f the residue from H20-EtOH-Et20  
furnished 80 mg (88% yield) of orange-yellow crystals, 
m.p. > 300 °. The sample was lyophilized from deuteri- 
um oxide to remove xchangeable protons and then 
dissolved in D20. The NMR spectrum (obtained using 
a Varian T-60 spectrometer with silapentanesulfonate 
as internal standard) exhibited apair of doublets at 
88.18 and 8.45 corresponding to the 11-. and 12-H's 
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Fig. 1. eFAD. 
of the 1, N 6-ethenoadenine portion. 
Glucose oxidase apoprotein was prepared accord- 
ing to the acid ammonium sulfate method of 
Swoboda [6]. The apoprotein of D-amino acid 
oxidase was prepared by the KBr dialysis method 
[7]. All nucleotides and enzymes were obtained 
from Sigma Chemical Co., St.Louis, Mo. 
Absorption spectra were recorded on a Bausch 
and Lomb 505 spectrophotometer; uncorrected 
fluorescence spectra were obtained using a recording 
spectrofluorometer [8] equipped with a 450 W 
xenon lamp. 
3. Results and discussion 
The absorption spectrum of eFAD, is virtually 
identical to that of FAD from 340 nm to 550 nm 
(fig. 2). However, eFAD shows a stronger absorption 
in the region from 270 nm to 330 nm and exhibits 
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Fig. 2. Absorption spectra of FAD (18 tJ, M) or eFAD(18 
a well-defined peak at 225 nm which is not present 
in the spectrum of FAD. The spectral differences in 
the ultraviolet region are consistent with the modifi- 
cation of the purine moiety of FAD since e-adeno- 
sine, in contrast o adenosine, exhibits an intense 
absorption peak at 230 nm, weaker absorption peaks 
at 275 nm and 265 nm, and a broad shoulder from 
280 nm to 340 nm [2]. 
eFAD contains two fluorescent moieties, the 
e-adenosine and the flavin component. Through a 
judicious selection of excitation and emission wave- 
lengths, it is possible to selectively observe the 
fluorescence properties of either the e-adenosine or 
the flavin portion of the coenzyme. For example, 
excitation of eFAD at 300 iLrn, the excitation 
maximum for e-adenosine, results in an emission 
peak at 410 nm (characteristic of e-adenosine deri- 
vatives) which is absent in the spectrum obtained 
with FAD (fig. 3). eFAD also exhibits a second 
emission peak at 525 nm which is substantially 
greater than seen with an equal concentration of 
FAD (fig. 3). In contrast, the emission of eFAD and 
FAD are virtually identical when excited at longer 
wavelengths where there is no absorption of light by 
the e-adenosine portion of the dinucleotide. 
~M) in 10 mM potassium phosphate buffer, pH 7.0. 
The enhanced ravin emission resulting from 
excitation at 300 nm indicates resonance nergy 
transfer from the e-adenosine moiety to the ravin 
part of the coenzyme. The efficiency of this trans- 
fer is approx. 50% as calculated from the excitation 
spectrum of the energy acceptor [9]. The fluores- 
cence of the e-adenosine and the ravin portions 
of eFAD are markedly quenched when compared 
to an equimolar solution of cAMP and FMN. These 
observations suggest hat in aqueous olution the 
e-aderine and isoalloxazine rings of eFAD exist in a 
stacked conformation, similar to that proposed for 
FAD [10]. 
eFAD provided almost full enzymic activity with 
apoglucose oxidase (table 1). This restoration of 
activity by eFAD was not due to contamination 
with unreacted FAD since apo-D amino acid 
oxidase is activated by the FAD but shows no acti- 
vity in the presence of the eFAD preparation (table 1). 
While a more extensive investigation of other taro- 
proteins will be required to fully evaluate the 
biological activity of eFAD, the present data suggest 
that the FAD analog may be useful in the study of 
enzyme mechanisms. For example, the efficiency of 
intramolecular energy transfer will depend on the 
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Fig. 3. Fluorescence emission spectra. FAD or eFAD 
(13 t~M) in 5 mM potassium phosphate buffer, pH 7.0, 
excitation at 300 nm. 
Table 1 
Coenzyme activity of eFAD. 
Conditions Enzyme 
activity a 
(A Aa4o/min) 
D-amino acid oxidase apoprotein 0.06 
D-amino acid oxidase apoprotein + FAD b 0.45 
D-amino acid oxidase apoprotein + eFAD b 0.07 
Glucose oxidase apoprotein 0.03 
Glucose oxidase apoprotein + FAD b 0.54 
Glucose oxidase apoprotein +eFAD b 0.42 
a) The D-amino acid oxidase assay contained 0.16 M Tris 
(pH 8.3), 0.0373 M D-alanine, 0.25 mM NADH, 0.33 ~tg[ 
ml  catalase, 16 ~g/ml lactate dehydrogenase, and approx. 
10 ~g/ml apo-D-amino acid oxidase. Reaction followed 
by decrease in absorbance at 340 nm. The glucose oxidase 
assay contained 0.083 M Tris (pH 7.0), 2.7 × 10 -4  M 
o-dianisidine, 0.092 M glucose, 3 ~g/ml peroxidase and 
approx. 8 t~g]ml apoglucose oxidase. Reaction followed 
by increase in absorbance at 346 nm. 
b) Apoprotein preincubated 15 rain with 4X 10 -7 M FAD 
or eFAD as indicated. 
relative spatial orientation of the two planar ring 
systems of eFAD; thus, it may be possible to 
determine if the enzyme-bound eFAD exists in a 
stacked or open conformation. Also, reduced eFAD 
is fluorescent (in contrast o FADH2) and may be 
potentially useful in investigating interaction between 
reduced coenzyme and apoptotein. 
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